T
Todd E. DeFor
Researcher at University of Minnesota
Publications - 297
Citations - 19625
Todd E. DeFor is an academic researcher from University of Minnesota. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 64, co-authored 288 publications receiving 17856 citations. Previous affiliations of Todd E. DeFor include City of Hope National Medical Center.
Papers
More filters
Journal ArticleDOI
Reduced intensity compared with high dose conditioning for allotransplantation in acute myeloid leukemia and myelodysplastic syndrome: A comparative clinical analysis
Catherine M. Flynn,Betsy A. Hirsch,Todd E. DeFor,Juliet N. Barker,Jeffrey S. Miller,John E. Wagner,Bruce R. Blazar,Linda J. Burns,Margaret L. MacMillan,Mukta Arora,Daniel J. Weisdorf +10 more
TL;DR: It is suggested that RI allografts can yield satisfactory DFS both for older as well as younger patients with pre‐existing comorbidities, who are ineligible for MA allografteds.
Journal ArticleDOI
Long-Term follow-up of a Phase I/II Randomized, Placebo-Controlled Trial of Palifermin to Prevent Graft-versus-Host Disease (GVHD) after Related Donor Allogeneic Hematopoietic Cell Transplantation (HCT)
TL;DR: The benefits of palifermin appear primarily to be limited to ameliorating mucotoxicity when given to allogeneic HCT recipients.
Journal ArticleDOI
Effect of Conditioning Regimen Intensity on Acute Myeloid Leukemia Outcomes after Umbilical Cord Blood Transplantation
TL;DR: UCB with RIC extends the use of allogeneic HCT for older and frail patients without excessive TRM with greater benefit for patients in CR1 and CR2 with longer CR1 with no independent predictors of TRM.
Journal ArticleDOI
A Randomized Trial of One versus Two Doses of Influenza Vaccine after Allogeneic Transplantation
Nicole Karras,Matthew A. Weeres,Wendy Sessions,Xiyan Xu,Todd E. DeFor,Jo Anne H. Young,Heather E. Stefanski,Claudio G. Brunstein,Sarah Cooley,Jeffrey S. Miller,Bruce R. Blazar,John E. Wagner,Michael R. Verneris +12 more
TL;DR: Time from transplantation to vaccination and absolute CD19(+) cell counts were the strongest predictors of vaccine responses, and there was a positive correlation between the total number of CD19+ cells before vaccination and seroconversion and an inverse correlation for IFN-γ responses.
Journal ArticleDOI
Similar and promising outcomes in lymphoma patients treated with myeloablative or nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation.
Marcie Tomblyn,Claudio G. Brunstein,Linda J. Burns,Jeffrey S. Miller,Margaret L. MacMillan,Todd E. DeFor,Daniel J. Weisdorf +6 more
TL;DR: It is concluded that similar transplant outcomes are achieved after allogeneic hematopoietic stem cell transplantation using MA conditioning in younger patients and NMA conditioning in older patients or those with prior autologous transplantation not eligible for MA conditioning.